Assessment of quality of life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: A post-marketing, multicenter, observational study.

[1]  M. Kudo,et al.  Long-term follow-up results of growth hormone therapy for patients with adult growth hormone deficiency. , 2015, Hormones.

[2]  J. E. Adalsteinsson,et al.  Impact of adult growth hormone deficiency on daily functioning and well-being , 2014, BMC Research Notes.

[3]  C. Strasburger,et al.  Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study. , 2014, The Journal of clinical endocrinology and metabolism.

[4]  J. E. Adalsteinsson,et al.  Assessing the impact of growth hormone deficiency and treatment in adults: development of a new disease-specific measure. , 2014, The Journal of clinical endocrinology and metabolism.

[5]  S. Lamberts,et al.  IGF-I bioactivity might reflect different aspects of quality of life than total IGF-I in GH-deficient patients during GH treatment. , 2013, The Journal of clinical endocrinology and metabolism.

[6]  K. Chihara,et al.  Development and Validation of a New Questionnaire Assessing Quality of Life in Adults with Hypopituitarism: Adult Hypopituitarism Questionnaire (AHQ) , 2012, PloS one.

[7]  S. Yamada,et al.  GH deficiency in patients after cure of acromegaly by surgery alone. , 2011, European journal of endocrinology.

[8]  T. Kohlmann,et al.  The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database. , 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[9]  K. Chihara,et al.  Efficacy and safety of individualized growth hormone treatment in adult Japanese patients with growth hormone deficiency. , 2008, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[10]  K. Chihara,et al.  A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. , 2007, European journal of endocrinology.

[11]  S. Fukuhara,et al.  Validation of the Japanese version of the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA). , 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[12]  M. Vance,et al.  Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[13]  K. Chihara,et al.  Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study. , 2006, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[14]  J. Svensson,et al.  Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[15]  K. Chihara,et al.  Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H). , 2004, The Journal of clinical endocrinology and metabolism.

[16]  C. Strasburger,et al.  Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module. , 2003, The Journal of clinical endocrinology and metabolism.

[17]  C. Strasburger,et al.  Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency. , 2001, European journal of endocrinology.

[18]  A. Barkan.  The "quality of life-assessment of growth hormone deficiency in adults" questionnaire: can it be used to assess quality of life in hypopituitarism? , 2001, The Journal of clinical endocrinology and metabolism.

[19]  B. Bengtsson,et al.  The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. , 1999, The Journal of clinical endocrinology and metabolism.

[20]  Murray,et al.  Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults , 1999, Clinical endocrinology.

[21]  Thomas Kohlmann,et al.  The QoL-AGHDA: An instrument for the assessment of quality of life in adults with growth hormone deficiency , 1999, Quality of Life Research.

[22]  R. Marcus,et al.  Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  A. Igout,et al.  Effect of oestrogen status on serum levels of growth hormone‐binding protein and insulin‐like growth factor‐I in non‐pregnant and pregnant women , 1993, Clinical endocrinology.

[24]  A. O’Sullivan,et al.  Effects of different oral oestrogen formulations on insulin‐like growth factor‐I, growth hormone and growth hormone binding protein in post‐menopausal women , 1993, Clinical endocrinology.